Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 3284 entries
View as:

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT00657527 Org: User:
Start: 12/31/01 End: 12/31/02 Due: 12/31/03

Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00573469 Org: User:
Start: 10/31/06 End: 03/31/08 Due: 03/31/09

Safety and Efficacy of Seroquel in First Episode Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00254241 Org: User:
Start: 05/31/02 End: 06/30/06 Due: 06/30/07

Epanova® for Lowering Very High Triglycerides II (EVOLVE II)

Phase: N/A Priority: Normal
NCT ID: NCT02009865 Org: User:
Start: 12/16/13 End: 12/23/14 Due: 12/23/15

Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration

Phase: N/A Priority: Normal
NCT ID: NCT01217645 Org: User:
Start: 09/30/10 End: 10/31/10 Due: 10/31/11

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00684307 Org: User:
Start: 02/28/07 End: 06/30/08 Due: 06/30/09

The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.

Phase: N/A Priority: Normal
NCT ID: NCT02430311 Org: User:
Start: 06/10/15 End: 04/28/17 Due: 04/28/18

SYMBICORT® in the Treatment of COPD

Phase: N/A Priority: Normal
NCT ID: NCT00564499 Org: User:
Start: 03/31/06 End: 05/31/07 Due: 05/31/08

Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00640601 Org: User:
Start: 03/31/08 End: 07/31/10 Due: 07/31/11

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00324363 Org: User:
Start: 01/31/06 End: 04/30/07 Due: 04/30/08

An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

Phase: N/A Priority: Normal
NCT ID: NCT00767585 Org: User:
Start: 08/31/08 End: 06/30/09 Due: 06/30/10

Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01082120 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01596530 Org: User:
Start: 06/30/12 End: 05/31/13 Due: 05/31/14

Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese

Phase: N/A Priority: Normal
NCT ID: NCT05511025 Org: User:
Start: 09/20/22 End: 12/19/23 Due: 12/19/24

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01309841 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib

Phase: N/A Priority: Normal
NCT ID: NCT01645085 Org: User:
Start: 07/31/12 End: 03/31/13 Due: 03/31/14

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

Phase: N/A Priority: Normal
NCT ID: NCT00884689 Org: User:
Start: 04/30/09 End: 06/30/10 Due: 06/30/11

Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00278941 Org: User:
Start: 12/31/05 End: 08/31/07 Due: 08/31/08

Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT04799067 Org: User:
Start: 05/17/21 End: 07/18/22 Due: 07/18/23

Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01240148 Org: User:
Start: 12/31/10 End: 03/31/11 Due: 03/31/12

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Phase: N/A Priority: Normal
NCT ID: NCT00422123 Org: User:
Start: 01/31/07 End: 07/31/07 Due: 07/31/08

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

Phase: N/A Priority: Normal
NCT ID: NCT00984880 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00517283 Org: User:
Start: 01/31/05 End: 06/30/05 Due: 06/30/06

Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04532918 Org: User:
Start: 09/10/20 End: 11/23/20 Due: 11/23/21

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg

Phase: N/A Priority: Normal
NCT ID: NCT00919477 Org: User:
Start: 05/31/09 End: 03/31/12 Due: 03/31/13